Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

Daptomycin RS-6

● Under Development

Katalog-Nr.::	VE0023733
CAS-Nr.::	N/A
Summenformel::	C72H101N17O27
Molare Masse::	1635.67 g/mol

Wie können wir helfen?

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu Daptomycin RS-6

Parent drug

Daptomycin

IUPAC-Name

2, 2′-(30-(2-(4-amino-2-(2-decanamido-3-(1H-indol-3-yl)propanamido)-4-oxobutanamido)-3-carboxypropanamido)-3-(2-(2-aminophenyl)-2-oxoethyl)-24-(3-aminopropyl)-6-(1-carboxypropan-2-yl)-9, 18-bis(hydroxymethyl)-31-methyl-2, 5, 8, 11, 14, 17, 20, 23, 26, 29-decaoxo-1-oxa-4, 7, 10, 13, 16, 19, 22, 25, 28 nonaazacyclohentriacontane-15, 21-diyl)diacetic acid

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

SMILES

NC1=CC=CC=C1C(CC2NC(C(NC(C(CO)NC(CNC(C(CC(O)=O)NC(C(NC(C(NC(C(NC(CNC(C(C(OC2=O)C)NC(C(NC(C(CC(N)=O)NC(C(CC3=CNC4=C3C=CC=C4)NC(CCCCCCCCC)=O)=O)=O)CC(O)=O)=O)=O)=O)CCCN)=O)CC(O)=O)=O)CO)=O)=O)=O)=O)C(C)CC(O)=O)=O)=O

InChI

InChI=1S/C72H101N17O27/c1-4-5-6-7-8-9-10-21-53(94)80-43(24-37-30-76-41-19-14-12-16-38(37)41)64(107)82-44(26-52(75)93)65(108)85-47(29-59(103)104)67(110)89-61-36(3)116-72(115)48(25-51(92)39-17-11-13-18-40(39)74)86-71(114)60(35(2)23-56(97)98)88-69(112)49(33-90)81-55(96)31-77-62(105)45(27-57(99)100)83-68(111)50(34-91)87-66(109)46(28-58(101)102)84-63(106)42(20-15-22-73)79-54(95)32-78-70(61)113/h11-14, 16-19, 30, 35-36, 42-50, 60-61, 76, 90-91H, 4-10, 15, 20-29, 31-34, 73-74H2, 1-3H3, (H2, 75, 93)(H, 77, 105)(H, 78, 113)(H, 79, 95)(H, 80, 94)(H, 81, 96)(H, 82, 107)(H, 83, 111)(H, 84, 106)(H, 85, 108)(H, 86, 114)(H, 87, 109)(H, 88, 112)(H, 89, 110)(H, 97, 98)(H, 99, 100)(H, 101, 102)(H, 103, 104)

Beschreibung

The Daptomycin RS-6 standard is a well-characterized compound that aligns with key regulatory guidelines | including USP | EMA | JP | and BP. It plays a crucial role in analytical method development | method validation (AMV) | and quality control (QC) processes | particularly in the manufacturing of Daptomycin. This impurity standard is valuable for both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | ensuring reliable and precise analytical outcomes.